\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ was\\ notable\\ for\\ periumbilical\\ tenderness\\ with\\ some\\ radiation\\ of\\ pain\\ bilaterally\\,\\ the\\ abdomen\\ was\\ soft\\ without\\ rebound\\ or\\ guarding\\ and\\ the\\ physical\\ exam\\ was\\ otherwise\\ unremarkable\\.\ \(0\)\
\-\ initial\\ laboratory\\ values\\ were\\ notable\\ for\\ albumin\\ of\\ 3\\.4\\,\\ alk\\ phos\\ 310\\,\\ ast\\ 83\\,\\ alt\\ 125\\,\\ total\\ bilirubin\\ 4\\.3\\,\\ esr\\ 44\\,\\ ggt\\ 109\\.\\ the\\ patient\\ was\\ admitted\\ for\\ pain\\ control\\ and\\ observation\\.\\ \ \(0\)\
\-\ the\\ first\\ day\\ of\\ admission\\ the\\ patient\\ clinically\\ worsened\\;\\ he\\ became\\ febrile\\ with\\ increasing\\ total\\ bilirubin\\ to\\ 7\\.5\\ and\\ right\\ upper\\ quadrant\\ pain\\ radiating\\ to\\ the\\ right\\ shoulder\\ concerning\\ for\\ acute\\ cholecystitis\\.\\ the\\ patient\\ also\\ developed\\ apparent\\ scleral\\ icterus\\.\ \(0\)\
\-\ the\\ patient\\ then\\ underwent\\ ercp\\ with\\ stone\\ removal\\ that\\ revealed\\ a\\ purulent\\ gallbladder\\ and\\ common\\ bile\\ duct\\.\\ he\\ is\\ currently\\ on\\ antibiotics\\ in\\ anticipation\\ of\\ cholecystectomy\\ following\\ resolution\\ of\\ acute\\ infection\\.\\ \ \(0\)\
\-\ after\\ discharge\\ he\\ will\\ be\\ maintained\\ on\\ his\\ home\\ regimen\\ of\\ ursodiol\\,\\ hydroxyzine\\,\\ and\\ lansoprazol\\ as\\ well\\ as\\ tramadol\\ as\\ needed\\ for\\ abdominal\\ pain\\ until\\ seen\\ by\\ gastroenterology\\.\ \(0\)\
\-\ the\\ presentation\\ ultrasound\\ showed\\ an\\ enlarged\\ common\\ hepatic\\ duct\\ with\\ patchy\\ areas\\ of\\ increased\\ echogenicity\\ believed\\ to\\ represent\\ fatty\\ infiltration\\ versus\\ fibrosis\\.\ \(0\)\
\-\ ct\\ imaging\\ initially\\ showed\\ mild\\ dilatation\\ of\\ the\\ common\\ bile\\ duct\\ and\\ left\\ intrahepatic\\ bile\\ duct\\ with\\ enhancement\\ of\\ the\\ gallbladder\\ wall\\ and\\ common\\ bile\\ duct\\ suggestive\\ of\\ cholangitis\\.\\ \ \(0\)\
\-\ ercp\\ early\\ on\\ showed\\ stricture\\ formation\\ in\\ the\\ bile\\ ducts\\ with\\ the\\ classic\\ \\‚\\Ä\\úbeads\\ on\\ a\\ string\\‚\\Ä\\ù\\ appearance\\ with\\ dilation\\ of\\ the\\ common\\ bile\\ duct\\.\\ \ \(0\)\
\-\ mrcp\\ at\\ \\ this\\ presentation\\ showed\\ increased\\ stricture\\ formation\\ at\\ the\\ proximal\\ left\\ branch\\,\\ the\\ cystic\\ duct\\ near\\ junction\\ with\\ common\\ hepatic\\ duct\\,\\ and\\ diffuse\\ narrowing\\ of\\ the\\ common\\ bile\\ duct\\ with\\ more\\ dilation\\ of\\ the\\ common\\ hepatic\\ duct\\ than\\ previous\\ mrcp\\.\\ imaging\\ also\\ showed\\ stones\\ present\\ in\\ the\\ cystic\\ duct\\ proximal\\ to\\ the\\ area\\ of\\ narrowing\\ with\\ sludge\\ in\\ the\\ common\\ hepatic\\ duct\\ proximal\\ to\\ the\\ narrowed\\ common\\ bile\\ duct\\.\\ the\\ gallbladder\\ was\\ found\\ to\\ be\\ distended\\ and\\ thickwalled\\ with\\ a\\ moderate\\ amount\\ of\\ adjacent\\ edema\\ consistent\\ with\\ acute\\ cholecystitis\\.\\ progression\\ of\\ the\\ beaded\\ appearance\\ of\\ the\\ intrahepatic\\ bile\\ ducts\\ was\\ also\\ demonstrated\\.\ \(0\)\
\-\ acute\\ cholecystitis\\ in\\ the\\ setting\\ of\\ primary\\ sclerosing\\ cholangitis\ \(0\)\
\-\ \\‚\\Ä\\¢\\ primary\\ sclerosing\\ cholangitis\ \(0\)\
\-\ \\‚\\Ä\\¢\\ secondary\\ sclerosing\\ cholangitis\\:\\ \\ ascending\\ cholangitis\\ as\\ \\ result\\ of\\ strictures\\,\\ stones\\,\\ or\\ bile\\ duct\\ anomalies\ \(0\)\
\-\ \\‚\\Ä\\¢\\ cholangiocarcinoma\ \(0\)\
\-\ this\\ 18\\ year\\ old\\ man\\ presented\\ 2\\ years\\ prior\\ to\\ his\\ primary\\ care\\ physician\\ with\\ complaints\\ of\\ abdominal\\ pain\\,\\ fatigue\\,\\ and\\ dizziness\\ and\\ was\\ diagnosed\\ with\\ primary\\ sclerosing\\ cholangitis\\.\\ the\\ patient\\ did\\ well\\ with\\ an\\ appropriate\\ medication\\ regimen\\ and\\ frequent\\ gi\\ follow\\ up\\ until\\ approximately\\ 2\\ years\\ after\\ diagnosis\\ when\\ he\\ presented\\ with\\ fatigue\\,\\ diarrhea\\,\\ and\\ abdominal\\ pain\\ \\-\\ unrelieved\\ by\\ tramadol\\.\ \(0\)\
\-\ the\\ patient\\ was\\ diagnosed\\ with\\ psc\\ based\\ on\\ initial\\ imaging\\ findings\\,\\ laboratory\\ values\\,\\ and\\ liver\\ biopsy\\ results\\ showed\\ mild\\ chronic\\ inflammation\\ of\\ the\\ portal\\ tract\\ without\\ evidence\\ of\\ sclerosing\\ acute\\ cholecystitis\\ was\\ diagnosed\\ with\\ imaging\\,\\ laboratory\\ values\\ and\\ clinical\\ examination\\ findings\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ duct\\:\\ 0\\.4379589994781707\ \(0\)\
\-\ bile\\:\\ 0\\.3528748220249825\ \(0\)\
\-\ cholangitis\\:\\ 0\\.25215827623162823\ \(0\)\
\-\ the\\:\\ 0\\.2102888477554764\ \(0\)\
\-\ common\\:\\ 0\\.20609490414167747\ \(0\)\
\-\ sclerosing\\:\\ 0\\.19140874391407578\ \(0\)\
\-\ of\\:\\ 0\\.15645885750451108\ \(0\)\
\-\ showed\\:\\ 0\\.1452339186890992\ \(0\)\
\-\ cholecystitis\\:\\ 0\\.14010966506454028\ \(0\)\
\-\ with\\:\\ 0\\.12808827951920831\ \(0\)\
\-\ hepatic\\:\\ 0\\.1157604404294249\ \(0\)\
\-\ was\\:\\ 0\\.11398667890089456\ \(0\)\
\-\ and\\:\\ 0\\.11264123644552469\ \(0\)\
\-\ values\\:\\ 0\\.10056434101593399\ \(0\)\
\-\ tramadol\\:\\ 0\\.10027220193027844\ \(0\)\
\-\ acute\\:\\ 0\\.09829536685292253\ \(0\)\
\-\ gallbladder\\:\\ 0\\.0974180540842178\ \(0\)\
\-\ mrcp\\:\\ 0\\.09056142377723625\ \(0\)\
\-\ primary\\:\\ 0\\.08938309523741607\ \(0\)\
\-\ he\\:\\ 0\\.08607915250788778\ \(0\)\
\-\ ercp\\:\\ 0\\.08511516230641845\ \(0\)\
\-\ regimen\\:\\ 0\\.08051532465271531\ \(0\)\
\-\ laboratory\\:\\ 0\\.07916926662337125\ \(0\)\
\-\ diagnosed\\:\\ 0\\.07897324241991405\ \(0\)\
\-\ bilirubin\\:\\ 0\\.07806422558324226\ \(0\)\
\-\ pain\\:\\ 0\\.07802481080337052\ \(0\)\
\-\ imaging\\:\\ 0\\.07639363058961063\ \(0\)\
\-\ intrahepatic\\:\\ 0\\.07628345417121847\ \(0\)\
\-\ ducts\\:\\ 0\\.07496873619480413\ \(0\)\
\-\ notable\\:\\ 0\\.0726874000419199\ \(0\)\
\-\ patient\\:\\ 0\\.07091935185832234\ \(0\)\
\-\ stricture\\:\\ 0\\.07039921732168702\ \(0\)\
\-\ fatigue\\:\\ 0\\.07039921732168702\ \(0\)\
\-\ stones\\:\\ 0\\.06861085944827255\ \(0\)\
\-\ proximal\\:\\ 0\\.06811132263299356\ \(0\)\
\-\ dilation\\:\\ 0\\.0639605604948342\ \(0\)\
\-\ to\\:\\ 0\\.06359619131563173\ \(0\)\
\-\ until\\:\\ 0\\.06048069334585819\ \(0\)\
\-\ abdominal\\:\\ 0\\.05962751538695415\ \(0\)\
\-\ total\\:\\ 0\\.0595536328323769\ \(0\)\
\-\ as\\:\\ 0\\.058397823653687696\ \(0\)\
\-\ ursodiol\\:\\ 0\\.05811711654930415\ \(0\)\
\-\ hydroxyzine\\:\\ 0\\.05811711654930415\ \(0\)\
\-\ lansoprazol\\:\\ 0\\.05811711654930415\ \(0\)\
\-\ formation\\:\\ 0\\.05762150144708451\ \(0\)\
\-\ narrowing\\:\\ 0\\.05634324334895519\ \(0\)\
\-\ anticipation\\:\\ 0\\.05553400751110117\ \(0\)\
\-\ thickwalled\\:\\ 0\\.05553400751110117\ \(0\)\
\-\ for\\:\\ 0\\.055073339886268335\ \(0\)\
\-\ on\\:\\ 0\\.05487797801156143\ \(0\)\
\-\ psc\\:\\ 0\\.05370126248170416\ \(0\)\
\-\ unrelieved\\:\\ 0\\.05227967499442109\ \(0\)\
\-\ also\\:\\ 0\\.051281247107988606\ \(0\)\
\-\ 310\\:\\ 0\\.05111815344350119\ \(0\)\
\-\ ggt\\:\\ 0\\.05013610096513922\ \(0\)\
\-\ presentation\\:\\ 0\\.05003302927736925\ \(0\)\
\-\ initial\\:\\ 0\\.048757819740453\ \(0\)\
\-\ beads\\:\\ 0\\.048535044405298204\ \(0\)\
\-\ beaded\\:\\ 0\\.0478638209268211\ \(0\)\
\-\ icterus\\:\\ 0\\.046702299375901195\ \(0\)\
\-\ gastroenterology\\:\\ 0\\.04619236883564225\ \(0\)\
\-\ scleral\\:\\ 0\\.045720246897539236\ \(0\)\
\-\ in\\:\\ 0\\.04520226499549173\ \(0\)\
\-\ years\\:\\ 0\\.04455305210806616\ \(0\)\
\-\ his\\:\\ 0\\.04407983999939657\ \(0\)\
\-\ appearance\\:\\ 0\\.043817120144742726\ \(0\)\
\-\ cystic\\:\\ 0\\.04377385537811564\ \(0\)\
\-\ periumbilical\\:\\ 0\\.043137137859336254\ \(0\)\
\-\ presented\\:\\ 0\\.042383986246026\ \(0\)\
\-\ string\\:\\ 0\\.04228644530830121\ \(0\)\
\-\ purulent\\:\\ 0\\.041776514768042255\ \(0\)\
\-\ strictures\\:\\ 0\\.041776514768042255\ \(0\)\
\-\ sludge\\:\\ 0\\.041304392829939245\ \(0\)\
\-\ mild\\:\\ 0\\.041201321142169275\ \(0\)\
\-\ albumin\\:\\ 0\\.04108083547924661\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.0404537002789042\ \(0\)\
\-\ 125\\:\\ 0\\.040257662326357656\ \(0\)\
\-\ maintained\\:\\ 0\\.040257662326357656\ \(0\)\
\-\ physical\\:\\ 0\\.03940981232739066\ \(0\)\
\-\ increased\\:\\ 0\\.03930293305395346\ \(0\)\
\-\ narrowed\\:\\ 0\\.03903211279162113\ \(0\)\
\-\ believed\\:\\ 0\\.038874802804932905\ \(0\)\
\-\ without\\:\\ 0\\.03833698680232641\ \(0\)\
\-\ alk\\:\\ 0\\.0380047168423779\ \(0\)\
\-\ phos\\:\\ 0\\.037610525304338054\ \(0\)\
\-\ febrile\\:\\ 0\\.03736066070044227\ \(0\)\
\-\ 83\\:\\ 0\\.03688853876233926\ \(0\)\
\-\ exam\\:\\ 0\\.036588121214521666\ \(0\)\
\-\ worsened\\:\\ 0\\.03624010862039342\ \(0\)\
\-\ findings\\:\\ 0\\.03587144901645634\ \(0\)\
\-\ infiltration\\:\\ 0\\.035841808258757664\ \(0\)\
\-\ became\\:\\ 0\\.03565162306800505\ \(0\)\
\-\ branch\\:\\ 0\\.03565162306800505\ \(0\)\
\-\ guarding\\:\\ 0\\.03555861804740626\ \(0\)\
\-\ echogenicity\\:\\ 0\\.03546695127505618\ \(0\)\
\-\ dizziness\\:\\ 0\\.03546695127505618\ \(0\)\
\-\ patchy\\:\\ 0\\.035376584784528084\ \(0\)\
\-\ ascending\\:\\ 0\\.035376584784528084\ \(0\)\
\-\ cholecystectomy\\:\\ 0\\.03528748220249825\ \(0\)\
\-\ after\\:\\ 0\\.035259196963918694\ \(0\)\
\-\ well\\:\\ 0\\.03519295004763211\ \(0\)\
\-\ alt\\:\\ 0\\.03494303449259441\ \(0\)\
\-\ radiating\\:\\ 0\\.03494303449259441\ \(0\)\
\-\ ast\\:\\ 0\\.034859755780395706\ \(0\)\
\-\ concerning\\:\\ 0\\.034859755780395706\ \(0\)\
\-\ portal\\:\\ 0\\.034777551662239295\ \(0\)\
\-\ anomalies\\:\\ 0\\.034696394758807786\ \(0\)\
\-\ rebound\\:\\ 0\\.03461625872402114\ \(0\)\
\-\ fatty\\:\\ 0\\.034537118193692276\ \(0\)\
\-\ diarrhea\\:\\ 0\\.03438172681288051\ \(0\)\
\-\ observation\\:\\ 0\\.03408187237344365\ \(0\)\
\-\ setting\\:\\ 0\\.03379549918387733\ \(0\)\
\-\ medication\\:\\ 0\\.03358886277477791\ \(0\)\
\-\ progression\\:\\ 0\\.03332337724577432\ \(0\)\
\-\ frequent\\:\\ 0\\.03332337724577432\ \(0\)\
\-\ esr\\:\\ 0\\.03325869922055469\ \(0\)\
\-\ stone\\:\\ 0\\.03319467123673807\ \(0\)\
\-\ discharge\\:\\ 0\\.032587475742077585\ \(0\)\
\-\ 44\\:\\ 0\\.03214022331154087\ \(0\)\
\-\ home\\:\\ 0\\.03214022331154087\ \(0\)\
\-\ versus\\:\\ 0\\.03214022331154087\ \(0\)\
\-\ appropriate\\:\\ 0\\.031927845953359964\ \(0\)\
\-\ physician\\:\\ 0\\.03187583969912994\ \(0\)\
\-\ control\\:\\ 0\\.031051097207456198\ \(0\)\
\-\ distended\\:\\ 0\\.031051097207456198\ \(0\)\
\-\ by\\:\\ 0\\.030864963936386196\ \(0\)\
\-\ gi\\:\\ 0\\.030527180424994416\ \(0\)\
\-\ fibrosis\\:\\ 0\\.030443901712795717\ \(0\)\
\-\ tract\\:\\ 0\\.030443901712795717\ \(0\)\
\-\ apparent\\:\\ 0\\.03040266706551036\ \(0\)\
\-\ admission\\:\\ 0\\.03032098991131178\ \(0\)\
\-\ represent\\:\\ 0\\.030240346672929096\ \(0\)\
\-\ clinically\\:\\ 0\\.03020040465642115\ \(0\)\
\-\ needed\\:\\ 0\\.03000436670387461\ \(0\)\
\-\ complaints\\:\\ 0\\.02992760998302711\ \(0\)\
\-\ admitted\\:\\ 0\\.02977681641618845\ \(0\)\
\-\ dilatation\\:\\ 0\\.02966601830584366\ \(0\)\
\-\ suggestive\\:\\ 0\\.02959320916176067\ \(0\)\
\-\ near\\:\\ 0\\.02959320916176067\ \(0\)\
\-\ resolution\\:\\ 0\\.029485532275702806\ \(0\)\
\-\ be\\:\\ 0\\.02948415438232772\ \(0\)\
\-\ inflammation\\:\\ 0\\.029206986018461507\ \(0\)\
\-\ junction\\:\\ 0\\.029105592937711346\ \(0\)\
\-\ amount\\:\\ 0\\.029072150704673068\ \(0\)\
\-\ increasing\\:\\ 0\\.028621507182449858\ \(0\)\
\-\ initially\\:\\ 0\\.02849839744305086\ \(0\)\
\-\ results\\:\\ 0\\.02831808170549538\ \(0\)\
\-\ shoulder\\:\\ 0\\.028229802268471483\ \(0\)\
\-\ currently\\:\\ 0\\.02791619068249102\ \(0\)\
\-\ an\\:\\ 0\\.027793327044868817\ \(0\)\
\-\ removal\\:\\ 0\\.027778588556436327\ \(0\)\
\-\ 18\\:\\ 0\\.027538155087889312\ \(0\)\
\-\ previous\\:\\ 0\\.027459985631529953\ \(0\)\
\-\ at\\:\\ 0\\.027452886064669904\ \(0\)\
\-\ moderate\\:\\ 0\\.027281235968465704\ \(0\)\
\-\ result\\:\\ 0\\.027206138076104242\ \(0\)\
\-\ classic\\:\\ 0\\.027181300887668035\ \(0\)\
\-\ developed\\:\\ 0\\.02696201890842947\ \(0\)\
\-\ antibiotics\\:\\ 0\\.0267732427038077\ \(0\)\
\-\ based\\:\\ 0\\.026324414139971348\ \(0\)\
\-\ early\\:\\ 0\\.026195708130935098\ \(0\)\
\-\ did\\:\\ 0\\.026069550923999103\ \(0\)\
\-\ care\\:\\ 0\\.02596629532875984\ \(0\)\
\-\ otherwise\\:\\ 0\\.02590513584371179\ \(0\)\
\-\ then\\:\\ 0\\.025725103214095272\ \(0\)\
\-\ biopsy\\:\\ 0\\.025473721588936304\ \(0\)\
\-\ quadrant\\:\\ 0\\.025454789239892726\ \(0\)\
\-\ or\\:\\ 0\\.025284750142485917\ \(0\)\
\-\ liver\\:\\ 0\\.02506967820810282\ \(0\)\
\-\ underwent\\:\\ 0\\.025034186580015196\ \(0\)\
\-\ this\\:\\ 0\\.02497482092898488\ \(0\)\
\-\ left\\:\\ 0\\.02479339239635336\ \(0\)\
\-\ enlarged\\:\\ 0\\.024774120643652028\ \(0\)\
\-\ areas\\:\\ 0\\.02467299580984456\ \(0\)\
\-\ first\\:\\ 0\\.024524256039756245\ \(0\)\
\-\ unremarkable\\:\\ 0\\.024362963101538092\ \(0\)\
\-\ bilaterally\\:\\ 0\\.024236805894602097\ \(0\)\
\-\ right\\:\\ 0\\.024097067926134707\ \(0\)\
\-\ radiation\\:\\ 0\\.024082543375450873\ \(0\)\
\-\ revealed\\:\\ 0\\.023828576750960596\ \(0\)\
\-\ adjacent\\:\\ 0\\.023556220576432033\ \(0\)\
\-\ area\\:\\ 0\\.02354220356139428\ \(0\)\
\-\ found\\:\\ 0\\.023514261715002645\ \(0\)\
\-\ will\\:\\ 0\\.02339001817406908\ \(0\)\
\-\ examination\\:\\ 0\\.023254753416240132\ \(0\)\
\-\ approximately\\:\\ 0\\.0231881830010572\ \(0\)\
\-\ day\\:\\ 0\\.023148572112217127\ \(0\)\
\-\ clinical\\:\\ 0\\.023031196065547502\ \(0\)\
\-\ some\\:\\ 0\\.022865381900865716\ \(0\)\
\-\ tenderness\\:\\ 0\\.02279028400850425\ \(0\)\
\-\ diffuse\\:\\ 0\\.02279028400850425\ \(0\)\
\-\ ultrasound\\:\\ 0\\.022415782544251764\ \(0\)\
\-\ demonstrated\\:\\ 0\\.022334180119594534\ \(0\)\
\-\ abdomen\\:\\ 0\\.02217404560137496\ \(0\)\
\-\ wall\\:\\ 0\\.022106629831908378\ \(0\)\
\-\ infection\\:\\ 0\\.021952046458043554\ \(0\)\
\-\ when\\:\\ 0\\.021952046458043554\ \(0\)\
\-\ following\\:\\ 0\\.021801125304347344\ \(0\)\
\-\ edema\\:\\ 0\\.02167455033087691\ \(0\)\
\-\ chronic\\:\\ 0\\.021570958930310382\ \(0\)\
\-\ secondary\\:\\ 0\\.02154020715331303\ \(0\)\
\-\ enhancement\\:\\ 0\\.02091722757668805\ \(0\)\
\-\ evidence\\:\\ 0\\.02062718689989282\ \(0\)\
\-\ than\\:\\ 0\\.020600660571084638\ \(0\)\
\-\ prior\\:\\ 0\\.020332834483337194\ \(0\)\
\-\ more\\:\\ 0\\.019955077428678785\ \(0\)\
\-\ consistent\\:\\ 0\\.01970490616369533\ \(0\)\
\-\ follow\\:\\ 0\\.019590936563171978\ \(0\)\
\-\ upper\\:\\ 0\\.019420049574064267\ \(0\)\
\-\ soft\\:\\ 0\\.01934715712250781\ \(0\)\
\-\ man\\:\\ 0\\.019239358767728563\ \(0\)\
\-\ diagnosis\\:\\ 0\\.018838899348640144\ \(0\)\
\-\ were\\:\\ 0\\.01873271804461714\ \(0\)\
\-\ present\\:\\ 0\\.01864773012446554\ \(0\)\
\-\ up\\:\\ 0\\.017976506645988436\ \(0\)\
\-\ seen\\:\\ 0\\.01710903268370542\ \(0\)\
\-\ that\\:\\ 0\\.01577061652710195\ \(0\)\
\-\ ct\\:\\ 0\\.013835347064840717\ \(0\)\
\-\ year\\:\\ 0\\.01119957031812586\ \(0\)\
\-\ old\\:\\ 0\\.010755464332876025\ \(0\)\
\-\ is\\:\\ 0\\.00995222051933219\ \(0\)\
